Publications by authors named "Lorand Sakallasz"
Acta Clin Croat
June 2009
Article Synopsis
- A study was conducted on 32 patients with relapsing-remitting multiple sclerosis (RRMS) treated with interferon beta-1b over three years, measuring its therapeutic effects and comparing the results with existing literature.
- The treatment resulted in a 60.5% reduction in annual relapse rates and a significant increase in disability status (EDSS), showcasing interferon beta-1b as an effective disease-modifying therapy.
- More than half of the patients (53.12%) remained relapse-free during treatment, and the findings align with global research, suggesting the therapy effectively decreases disease activity while presenting few serious side effects.
